Search Within

Emmet John Jordan

Formats
  1. Meeting Abstract (24)
  2. Journal Article (22)
  3. Research Letter (1)
Groups
  1. Department of Medicine (45)
  2. Solid Tumor Oncology Division (45)
  3. Department of Pathology and Laboratory Medicine (37)
  4. GSK Faculty (37)
  5. Human Oncology and Pathogenesis Program (36)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (31)

More Groups

People
  1. Michael Berger (30)
  2. David Solit (29)
  3. Gopakumar Iyer (17)
  4. Maeve Lowery (16)
  5. Maria Arcila (16)
  6. Eileen O'Reilly (14)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (1)
  4. 2019 (5)
  5. 2018 (7)
  6. 2017 (10)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Clinical Cancer Research (6)
  3. Laboratory Investigation (3)
  4. Modern Pathology (3)
  5. Cancer (2)
  6. JCO Precision Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. American Association for Cancer Research (8)
  3. Nature Publishing Group (6)
  4. Nature Research (3)
  5. Elsevier Inc. (2)
  6. Wiley Blackwell (2)

More Publishers

Results (47)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive molecular analysis of plasmacytoid variant urothelial carcinoma
    Meeting Abstract

    Al-Ahmadie, H. A.; Iyer, G.; Lee, B. H.; Scott, S. N.; Mehra, R.; Bagrodia, A.; Jordan, E. J.; Gao, S. P.; Ramirez, R.; Cha, E. K.; more...
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • The correlation of TP53 and RB1 genetic alterations and immunohistochemical (IHC) expression in invasive and non-invasive urothelial carcinoma
    Meeting Abstract

    Zheng, X.; Ren, Q.; Sarungbam, J.; Jordan, E. J.; Tickoo, S. K.; Fine, S.; Chen, Y. B.; Berger, M. F.; Gopalan, A.; Sirintrapun, S. J.; more...
    Laboratory Investigation (2016)

    Fulltext@MSK | Save
  • Comprehensive molecular analysis of plasmacytoid variant urothelial carcinoma
    Meeting Abstract

    Al-Ahmadie, H. A.; Iyer, G.; Lee, B. H.; Scott, S. N.; Mehra, R.; Bagrodia, A.; Jordan, E. J.; Gao, S. P.; Ramirez, R.; Cha, E. K.; more...
    Laboratory Investigation (2016)

    Fulltext@MSK | Save
  • Targeted therapy in advanced bladder cancer: What have we learned?
    Journal Article

    Jordan, E. J.; Iyer, G.
    Urologic Clinics of North America (2015)

    Fulltext@MSK | Save
  • Assessment of genomic alterations in bladder adenocarcinoma and urachal adenocarcinoma
    Meeting Abstract

    Jordan, E.; Won, H.; Toubaji, A.; Bagrodia, A.; Desai, N.; Bajorin, D.; Rosenberg, J.; Bochner, B.; Kim, W.; Berger, M.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Association of somatic mutations in DNA damage repair (DDR) genes with efficacy of platinum-based chemotherapy in advanced urothelial carcinoma
    Meeting Abstract

    Bambury, R. M.; Jordan, E.; Zabor, E. C.; Bouvier, N.; Al-Ahmadie, H.; Boyd, M. E.; Mullane, S. A.; Cha, E. K.; Ostrovnaya, I.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Split-dose cisplatin as an alternative to every-3-week dosing when using cisplatin/gemcitabine to treat advanced urothelial
    Meeting Abstract

    Gonzalez, C. M.; Jordan, E.; Zabor, E. C.; Kania, B. E.; Regazzi, A. M.; Ostrovnaya, I.; Iyer, G.; Bajorin, D. F.; Bambury, R. M.; Rosenberg, J. E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save